Neuroimaging and Genetics of Antidepressant Response to Sleep Deprivation: Implications for Drug Development
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Despite confirmed evidences about some neurochemical effects of antidepressant treatments, there is still a high level of uncertainty about which biological changes are needed to recover from a major depressive episode. Changes of monoaminergic neurotransmission are paralleled by profound changes in brain metabolism, neural responses to stimuli, sleep architecture, biological rhythms, and, at the intracellular level, neuronal signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms. Sleep deprivation targets the biological mechanisms which are responsible for the possibility, unique to mood disorders, of rapid switching between depression, euthymia, and mania. The rapidity of action of sleep deprivation enables the study of the correlates of antidepressant response at close time points, providing a good model to study the biological basis of the antidepressant response and of the pathophysiology of affective illness. Current knowledge suggests that multiple neurobiological effects of sleep deprivation are responsible for the clinical mood amelioration, suggesting a multi-target mechanism of action. An impressive group of brain imaging studies using different brain imaging techniques (positron emission tomography, single photon emission tomography, functional magnetic resonance imaging, proton spectroscopy, arterial spin labeling) showed that clinical response is associated with changes in the functioning of specific brain areas. The combination of these new methodological acquisitions with the classical neurobiological and pharmacogenetic perspective provides an evolving knowledge about brain changes associated with antidepressant response, and will then help to identify the real targets of antidepressant treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of the medial frontal cortex in cognitive control
Ridderinkhof, K. R., Ullsperger, M., Crone, E. A., & Nieuwenhuis, S. (2004) · Science · doi:10.1126/science.1100301 · Cited by 2,974
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“This line of reasoning is likely to provide many future advancements in the field, and links both to early hypotheses about the two-process model of sleep regulation [8], and to current hypotheses about the role of neurotrophins and neuroplastic changes in depression and antidepressant action [159].”
BackgroundMayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Sleep function and synaptic homeostasis
Tononi, G., & Cirelli, C. (2006) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.05.002 · Cited by 2,151 · cited 1×
“Accumulating evidence suggests then that plastic processes occurring during wakefulness result in a net increase in synaptic strength in many brain circuits, and that synaptic strength is downscaled to baseline levels during sleep [156], when effective cortico-cortical connectivity is broken down [157].”
BackgroundPezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2005) · Nature Neuroscience · doi:10.1038/nn1463 · Cited by 1,980 · cited 2×
“BOLD fMRI showed that activity in ACC during perceptual processing of fearful stimuli is tightly coupled with that of limbic structures, contributing to feedback circuits implicated in the extinction of negative affect [89], in the overall cognitive control of emotion experience , and in providing a neural basis for m…”
BackgroundBreakdown of cortical effective connectivity during sleep
Massimini, M., Ferrarelli, F., Huber, R., Esser, S. K., Singh, H., & Tononi, G. (2005) · Science · doi:10.1126/science.1117256 · Cited by 1,534
The Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar Depression
McGuffin, P., Rijsdijk, F., Andrew, M., Sham, P., Katz, R., & Cardno, A. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.497 · Cited by 1,243
Sleep and synaptic homeostasis: a hypothesis
Tononi, G., & Cirelli, C. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.09.004 · Cited by 1,217 · cited 1×
“According to this “synaptic homeostasis hypothesis” of sleep [158], SD should cause marked changes in neuronal connectivity resulting in major changes of brain metabolism and function which could be related to its antidepressant action.”
BackgroundMayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166
Neural circuitry underlying voluntary suppression of sadness
Lévesque, J., Eugène, F., Joanette, Y., Paquette, V., Mensour, B., Beaudoin, G., Leroux, J.-M., Bourgouin, P., & Beauregard, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01817-6 · Cited by 689
Pizzagalli, D., Pascual-Marqui, R. D., Nitschke, J. B., Oakes, T. R., Larson, C. L., Abercrombie, H. C., Schaefer, S. M., Koger, J. V., Benca, R. M., & Davidson, R. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.405 · Cited by 630
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553
The neural substrates of affective processing in depressed patients treated with venlafaxine
Davidson, R. J., Irwin, W., Anderle, M. J., & Kalin, N. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.64 · Cited by 487
Sleep deprivation in depression: what do we know, where do we go?
Wirz-Justice, A., & Van den Hoofdakker, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00125-0 · Cited by 429 · cited 2×
“This line of reasoning is likely to provide many future advancements in the field, and links both to early hypotheses about the two-process model of sleep regulation [8], and to current hypotheses about the role of neurotrophins and neuroplastic changes in depression and antidepressant action [159].”
BackgroundComplex Interaction of the Sleep-Wake Cycle and Circadian Phase Modulates Mood in Healthy Subjects
Boivin, D. B. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140055010 · Cited by 378 · cited 1×
“The normal fluctuation of mood in human beings seems to be regulated by a circadian process, independent of sleep, and by a sleep-dependent process, with perceived mood being influenced by a complex and nonadditive interaction of circadian phase and duration of prior wakefulness [21].”
BackgroundCirelli, C., & Tononi, G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09187.2000 · Cited by 369 · cited 1×
“Some authors [128], however, stressed the fact that (1) SD increases levels and expression of plasticity related molecules such as pCREB, BDNF, and BDNF’s receptor TrkB; and (2) lesions of the noradrenergic system abolished this effect [132].”
BackgroundRole of GSK3β in behavioral abnormalities induced by serotonin deficiency
Beaulieu, J.-M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711496105 · Cited by 368
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.2.201 · Cited by 346
Benedetti, F., Serretti, A., Colombo, C., Barbini, B., Lorenzi, C., Campori, E., & Smeraldi, E. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20038 · Cited by 324 · cited 1×
“Genes of the biological clock are expressed in many brain structures other than in the “master clock” SCN, and common individual genetic variants have been shown to influence not only the diurnal pattern of activity and sleep, but also core components of the illness such as age of onset [148, 149], illness recurrence…”
BackgroundSelf-citationTardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303 · cited 1×
“neurotrophic mechanisms [1].”
Chronotherapeutics (light and wake therapy) in affective disorders
WIRZ-JUSTICE, A., BENEDETTI, F., BERGER, M., LAM, R. W., MARTINY, K., TERMAN, M., & WU, J. C. (2005) · Psychological Medicine · doi:10.1017/s003329170500437x · Cited by 291 · cited 2×
“The basic idea is that the unique clinical effect of SD could be due to specific actions on molecular targets which have not yet been exploited in drug research and development, and the identification of the correlates of antidepressant response in human beings could provide new concepts to be translated from bedside…”
BackgroundSelf-citationTan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm069 · Cited by 266
Frodl, T., Meisenzahl, E. M., Zetzsche, T., Höhne, T., Banac, S., Schorr, C., Jäger, M., Leinsinger, G., Bottlender, R., Reiser, M., et al. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0407 · Cited by 227
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205 · cited 1×
“The pharmacogenetic interest for GSK3- comes from a promoter SNP (-50 T/C) which has been associated with transcriptional strength in vitro (greater activity of the T allele) [143].”
BackgroundBenedetti, F., Serretti, A., Colombo, C., Lorenzi, C., Tubazio, V., & Smeraldi, E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.050 · Cited by 195 · cited 1×
“This polymorphism influenced, in the same direction, acute antidepressant response to SD, with bipolar depressed homozygotes carriers of the C allele showing better mood amelioration after the night awake (day 1 response) and a relapse similar to the other groups after recovery sleep [146].”
BackgroundBenedetti, F., Serretti, A., Pontiggia, A., Bernasconi, A., Lorenzi, C., Colombo, C., & Smeraldi, E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.022 · Cited by 184 · cited 1×
“Consistent data showed that homozygotes carriers of the low-activity allele have a better clinical response to lithium both in the lifetime prevention of illness recurrences [144], and in the augmentation therapy of depressive episodes [145].”
BackgroundSelf-citationBenedetti, F., Barbini, B., Fulgosi, M. C., Colombo, C., Dallaspezia, S., Pontiggia, A., & Smeraldi, E. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1207 · Cited by 180
Self-citationDark therapy for mania: a pilot study
Barbini, B., Benedetti, F., Colombo, C., Dotoli, D., Bernasconi, A., Cigala‐Fulgosi, M., Florita, M., & Smeraldi, E. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00166.x · Cited by 169
Self-citationBenedetti, F., Serretti, A., Colombo, C., Campori, E., Barbini, B., di Bella, D., & Smeraldi, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1450 · Cited by 167
Self-citationPerspectives for the development of animal models of bipolar disorder
Machado-Vieira, R., Kapczinski, F., & Soares, J. C. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.10.015 · Cited by 158 · cited 1×
“Rapid behavioural activations closely resembling human mania and following a dose-response effect and a pattern of progressive sensitization have been described in rodents after sleep loss [42], and provide an animal model of mania with face, construct, and predictive validity [43].”
BackgroundA length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder
Benedetti, F., Dallaspezia, S., Colombo, C., Pirovano, A., Marino, E., & Smeraldi, E. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.002 · Cited by 149
Self-citationRoy-Byrne, P. P. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800090085011 · Cited by 142 · cited 1×
“A large proportion of normal human subjects experiences no changes or a worsening of mood after SD, an effect which seems to depend on individual differences in the timing of biological and behavioral rhythms [18], and which is shared by patients affected by non-depressive psychiatric conditions such as panic attacks…”
BackgroundColombo, C., Lucca, A., Benedetti, F., Barbini, B., Campori, E., & Smeraldi, E. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00164-5 · Cited by 139 · cited 1×
“In the absence of combined treatments, only a 5-10% of responders achieves a sustained remission from the depressive episode [13, 14].”
BackgroundSelf-citationSprouse, J., Braselton, J., & Reynolds, L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.003 · Cited by 122 · cited 2×
“Although data about the interaction bewteen the circadian clock and the sleep homeostat in regulating depressed mood are lacking, some preliminary studies suggest that changes in the phase of biological rhythms are needed for the behavioural effects of both antidepressant drugs and the therapeutic effect of SD [28-30].”
BackgroundSmeraldi, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00129-8 · Cited by 116
Self-citationGillin, J. C., Buchsbaum, M., Wu, J., Clark, C., & Bunney, W. (2001) · Depression and Anxiety · doi:10.1002/da.1045 · Cited by 103 · cited 4×
“Analyses of available literature data showed that SD has been used to treat more than 1700 depressed patients in more than 75 studies [6], and consistently caused a rapid reversal of depressive symptoms in approximately 40–60% of depressed patients [9, 10].”
BackgroundMethodInfluentialBenedetti, F., Dallaspezia, S., Fulgosi, M. C., Barbini, B., Colombo, C., & Smeraldi, E. (2007) · Chronobiology International · doi:10.1080/07420520701649455 · Cited by 97 · cited 2×
“Although data about the interaction bewteen the circadian clock and the sleep homeostat in regulating depressed mood are lacking, some preliminary studies suggest that changes in the phase of biological rhythms are needed for the behavioural effects of both antidepressant drugs and the therapeutic effect of SD [28-30].”
BackgroundSelf-citationBehavioural sensitization to repeated sleep deprivation in a mice model of mania
BENEDETTI, F., FRESI, F., MACCIONI, P., & SMERALDI, E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.012 · Cited by 85 · cited 1×
“Rapid behavioural activations closely resembling human mania and following a dose-response effect and a pattern of progressive sensitization have been described in rodents after sleep loss [42], and provide an animal model of mania with face, construct, and predictive validity [43].”
BackgroundSelf-citation(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.404 · Cited by 65
Benedetti, F., Calabrese, G., Bernasconi, A., Cadioli, M., Colombo, C., Dallaspezia, S., Falini, A., Radaelli, D., Scotti, G., & Smeraldi, E. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2008.08.004 · Cited by 53
Self-citationDopamine agonist amineptine prevents the antidepressant effect of sleep deprivation
Benedetti, F., Barbini, B., Campori, E., Colombo, C., & Smeraldi, E. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)03000-4 · Cited by 48 · cited 2×
“In the first trial three cycles of SD were administered after 6 days of amineptine treatment, and failed to further enhance antidepressant effects as if in presence of a kind of “ceiling effect” or a down regulation of pre- and postsynaptic DA receptors due to amineptine pretreatment [100].”
BackgroundSelf-citationPayne, J. L., Quiroz, J. A., Zarate, C. A., & Manji, H. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01676-1 · Cited by 46 · cited 2×
“Brain NE receptors show a circadian rhythm, and it was hypothesized that the “unexpected” NE discharge during SD could contribute to explain its unique effects [107, 128].”
Background
Cited by
The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments
Machado-Vieira, R., Baumann, J., Wheeler-Castillo, C., Latov, D., Henter, I. D., Salvadore, G., & Zarate, C. A. (2010) · Pharmaceuticals · doi:10.3390/ph3010019 · Cited by 263
“Recently, the ROAA associated with SD was found to correlate with serum BDNF changes in MDD [134].”
BackgroundGottlieb, J. F., Benedetti, F., Geoffroy, P. A., Henriksen, T. E. G., Lam, R. W., Murray, G., Phelps, J., Sit, D., Swartz, H. A., Crowe, M., et al. (2019) · Bipolar Disorders · doi:10.1111/bdi.12847 · Cited by 196
Self-citationBenedetti, F., Riccaboni, R., Locatelli, C., Poletti, S., Dallaspezia, S., & Colombo, C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08455 · Cited by 116
Self-citationSuzuki, M., Dallaspezia, S., Locatelli, C., Uchiyama, M., Colombo, C., & Benedetti, F. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.066 · Cited by 22
Self-citationCircadian and epigenetic control of depression-like behaviors
Sato, S., & Sassone-Corsi, P. (2019) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.05.010 · Cited by 10
Metadata
- Authors
- Benedetti, F., & Smeraldi, E.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-08-01
- Volume
- 15
- Issue
- 22
- Pages
- 2637-2649
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2077752708
- Cited by
- 60
- References
- 42
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.